The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II open-label study of enfortumab vedotin in patients with previously treated locally advanced, recurrent, or metastatic pancreatic adenocarcinoma (EPIC).
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
 
Raed Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Milind Phadnis
No Relationships to Disclose
 
Joaquina Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Merus; Moderna Therapeutics; Novo Nordisk; Zymeworks
Research Funding - Astellas Pharma (Inst); Chungchun Intellicrown (Inst); Exelixis (Inst); Genentech/Roche (Inst); IMPAC Medical Systems (Inst); Merck (Inst); Poseida (Inst); Sanofi (Inst); Synermore (Inst); Xencor (Inst)
 
Haoran Li
No Relationships to Disclose
 
Gregory Crane
No Relationships to Disclose
 
Jeremy Flanagan
No Relationships to Disclose
 
Deepti Satelli
No Relationships to Disclose
 
Erin Carroll
No Relationships to Disclose
 
Cathey Belcher
No Relationships to Disclose
 
Shannon Bradbury
No Relationships to Disclose
 
Marc Roth
Consulting or Advisory Role - Tempus
 
Sean Kumer
No Relationships to Disclose
 
Timothy Schmitt
No Relationships to Disclose
 
Clay King
No Relationships to Disclose
 
Mojtaba Olyaee
No Relationships to Disclose
 
Amit Rastogi
No Relationships to Disclose
 
Reza Hejazi
No Relationships to Disclose
 
Lauren Clark
No Relationships to Disclose
 
Weijing Sun
Honoraria - Astellas Pharma; Merck
Consulting or Advisory Role - Astellas Pharma; Merck
Research Funding - AstraZeneca (Inst); Merck (Inst); Novella Clinical (Inst)